GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA.  GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery.